Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Micrus’ MicroCoil

This article was originally published in The Gray Sheet

Executive Summary

Mountain View, California firm's endovascular coil was used in the International Subarachnoid Aneurysm Trial (ISAT), the firm reports. About 43 medical centers in North America, Australia and Europe participated in the study, published in the Oct. 25 issue of the Lancet (1"The Gray Sheet" Oct. 28, 2002, p. 18). Hospitals purchased the devices from Micrus and Boston Scientific (GDC); neither firm provided funding for the study. Additional study data on cost effectiveness, quality of life, neuropsychological, angiographic findings, and re-bleed rates are still being collected...
Advertisement

Related Content

GDC Coil Reduces Brain Aneurysm Mortality Risk v. Surgery, Study Finds
GDC Coil Reduces Brain Aneurysm Mortality Risk v. Surgery, Study Finds
Advertisement
UsernamePublicRestriction

Register

MT017457

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel